Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CSPC Pharmaceutical Group ( (HK:1093) ) just unveiled an update.
CSPC Pharmaceutical Group Limited announced the on-market purchase of 6,000,000 shares as part of its restricted share award scheme, representing approximately 0.052% of the total shares in issue. This strategic move is aimed at benefiting selected participants and reflects the company’s ongoing commitment to incentivize and retain talent, potentially strengthening its market position and shareholder value.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a Hong Kong-based company operating in the pharmaceutical industry. It focuses on the development, production, and sale of pharmaceutical products, with a market emphasis on innovative drug development and healthcare solutions.
Average Trading Volume: 171,854,398
Technical Sentiment Signal: Buy
Current Market Cap: HK$109.6B
For detailed information about 1093 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges